Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -11.600% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) COc1ccc(NC(=O)c2ccc(-n3cncn3)c([N+](=O)[O-])c2)cc1
b.) CCCNC(=O)N[C@@H](Cc1ccccc1)C(=O)OC
c.) N#Cc1ccccc1Oc1ccccc1C=O
Answer: b. CCCNC(=O)N[C@@H](Cc1ccccc1)C(=O)OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)N[C@@H](Cc1ccccc1)C(=O)OC
CCCNC(=O)N[C@@H](Cc1ccccc1)C(=O)OC
methyl (2S)-3-phenyl-2-(propylcarbamoylamino)propanoate